Increase in cardiac ischemia-reperfusion injuries in Opa1+/- mouse model

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Le Page, Sophie ^a,b,c   Niro, Marjorie ^a,b,c   Fauconnier, Jérémy ^d   Cellier, Laura ^a,b   Tamareille, Sophie ^a,b   Gharib, Abdallah ^e   Chevrollier, Arnaud ^a,f   Loufrani, Laurent ^a,f   Grenier, Céline ^a,f   Kamel, Rima ^a,b   Sarzi, Emmanuelle ^g   Lacampagne, Alain ^d   Ovize, Michel ^e   Henrion, Daniel ^a,f   Reynier, Pascal ^a,f   Lenaers, Guy ^a,f   Mirebeau Prunier, Delphine ^a,f   Prunier, Fabrice ^a,b,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF MONTPELLIER   (France)

^e CarMeN   (France)

^f UNIVERSITÉ D'ANGERS   (France)

^g Montpellier University Medical Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; OPA1 PROTEIN; PHOSPHOLAMBAN; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG; CALCIUM; CARRIER PROTEIN; GUANOSINE TRIPHOSPHATASE; HOMEODOMAIN PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; OPA1 PROTEIN (GTPASE), MOUSE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TLX2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CARDIAC MUSCLE CELL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EX VIVO STUDY; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; IN VIVO STUDY; MALE; MITOCHONDRIAL PERMEABILITY; MORPHOLOGY; MOUSE; MOUSE MODEL; MOUSE MUTANT; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; WHOLE CELL PATCH CLAMP; WILD TYPE; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MITOCHONDRIAL DYNAMICS; MUTANT MOUSE STRAIN;

ANIMALS; CALCIUM; DISEASE MODELS, ANIMAL; GTP PHOSPHOHYDROLASES; HOMEODOMAIN PROTEINS; MICE; MICE, MUTANT STRAINS; MITOCHONDRIA, HEART; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84991434410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164066     Document Type: Article

References (39)

1. Hall AR, Burke N, Dongworth RK, Hausenloy DJ. Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol 2014; 171:1890-1906. doi: 10. 1111/bph. 12516 PMID: 24328763
2. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012; 337:1062-1065. doi: 10. 1126/science. 1219855 PMID: 22936770
3. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000; 26:211-215. doi: 10. 1038/79944 PMID: 11017080
4. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000; 26:207-210. doi: 10. 1038/79936 PMID: 11017079
5. Chao de la Barca JM, Prunier-Mirebeau D, Amati-Bonneau P, Ferre M, Sarzi E, Bris C, et al. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology. Neurobiol Dis 2016; 90:20-26. doi: 10. 1016/j. nbd. 2015. 08. 015 PMID: 26311407
6. Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010; 121:2012-2022. doi: 10. 1161/CIRCULATIONAHA. 109. 906610 PMID: 20421521
7. Disatnik MH, Ferreira JC, Campos JC, Gomes KS, Dourado PM, Qi X et al. Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J Am Heart Assoc 2013; 2:e000461. doi: 10. 1161/JAHA. 113. 000461 PMID: 24103571
8. Sharp WW, Fang YH, Han M, Zhang HJ, Hong Z, Banathy A et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. Faseb j 2014; 28:316-326. doi: 10. 1096/fj. 12-226225 PMID: 24076965
9. Zepeda R, Kuzmicic J, Parra V, Troncoso R, Pennanen C, Riquelme JA et al. Drp1 loss-of-function reduces cardiomyocyte oxygen dependence protecting the heart from ischemia-reperfusion injury. J Cardiovasc Pharmacol 2014; 63:477-487. doi: 10. 1097/FJC. 0000000000000071 PMID: 24477044
10. Papanicolaou KN, Khairallah RJ, Ngoh GA, Chikando A, Luptak I, O'Shea KM et al. Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes. Mol Cell Biol 2011; 31:1309-1328. doi: 10. 1128/MCB. 00911-10 PMID: 21245373
11. Chen L, Gong Q, Stice JP, Knowlton AA. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 2009; 84:91-99. doi: 10. 1093/cvr/cvp181 PMID: 19493956
12. Chen L, Liu T, Tran A, Lu X, Tomilov AA, Davies V et al. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc 2012; 1:e003012. doi: 10. 1161/JAHA. 112. 003012 PMID: 23316298
13. Piquereau J, Caffin F, Novotova M, Prola A, Garnier A, Mateo P et al. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc Res 2012; 94:408-417. doi: 10. 1093/cvr/cvs117 PMID: 22406748
14. Ferre M, Caignard A, Milea D, Leruez S, Cassereau J, Chevrollier A et al. Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data. Hum Mutat 2015; 36:20-25. doi: 10. 1002/humu. 22703 PMID: 25243597
15. Sarzi E, Angebault C, Seveno M, Gueguen N, Chaix B, Bielicki G et al. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse. Brain 2012; 135:3599-3613. doi: 10. 1093/brain/aws303 PMID: 23250881
16. Prunier F, Gaertner R, Louedec L, Michel JB, Mercadier JJ, Escoubet B. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol 2002; 283:H346-352. doi: 10. 1152/ajpheart. 01050. 2001 PMID: 12063308
17. 2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes 2005; 54:2375-2381. doi: 10. 2337/diabetes. 54. 8. 2375 PMID: 16046304
18. Paillard M, Tubbs E, Thiebaut PA, Gomez L, Fauconnier J, Da Silva CC et al. Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation 2013; 128:1555-1565. doi: 10. 1161/CIRCULATIONAHA. 113. 001225 PMID: 23983249
19. Dague E, Genet G, Lachaize V, Guilbeau-Frugier C, Fauconnier J, Mias C et al. Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure. J Mol Cell Cardiol 2014; 74:162-172. doi: 10. 1016/j. yjmcc. 2014. 05. 006 PMID: 24839910
20. 2+ current-mediated regulation of action potential by pacing rate in rat ventricular myocytes. Cardiovasc Res 2003; 57:670-680. doi: 10. 1016/S0008-6363(02)00731-9 PMID: 12618229
21. Wilding JR, Joubert F, de Araujo C, Fortin D, Novotova M, Veksler V et al. Altered energy transfer from mitochondria to sarcoplasmic reticulum after cytoarchitectural perturbations in mice hearts. J Physiol 2006; 575:191-200. doi: 10. 1113/jphysiol. 2006. 114116 PMID: 16740607
22. Teixeira G, Chiari P, Fauconnier J, Abrial M, Couture-Lepetit E, Harisseh R et al. Involvement of Cyclophilin D and Calcium in Isoflurane-induced Preconditioning. Anesthesiology 2015; 123:1374-1384. doi: 10. 1097/ALN. 0000000000000876 PMID: 26460965
23. Gharib A, De Paulis D, Li B, Augeul L, Couture-Lepetit E, Gomez L et al. Opposite and tissue-specific effects of coenzyme Q2 on mPTP opening and ROS production between heart and liver mitochondria: role of complex I. J Mol Cell Cardiol 2012; 52:1091-1095. doi: 10. 1016/j. yjmcc. 2012. 02. 005 PMID: 22387164
24. Kalakech H, Tamareille S, Pons S, Godin-Ribuot D, Carmeliet P, Furber A et al Role of hypoxia inducible factor-1alpha in remote limb ischemic preconditioning. J Mol Cell Cardiol 2013; 65:98-104. doi: 10. 1016/j. yjmcc. 2013. 10. 001 PMID: 24140799
25. Tamareille S, Mateus V, Ghaboura N, Jeanneteau J, Croue A, Henrion D et al. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol 2011; 106:1329-1339. doi: 10. 1007/s00395-011-0210-z PMID: 21833651
26. Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 2015; 116:674-699. doi: 10. 1161/CIRCRESAHA. 116. 305348 PMID: 25677517
27. Gomez L, Li B, Mewton N, Sanchez I, Piot C, Elbaz M et al. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res 2009; 83:226-233. doi: 10. 1093/cvr/cvp063 PMID: 19221132
28. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 2010; 105:151-154. doi: 10. 1007/s00395-009-0080-9 PMID: 20066536
29. Brady NR, Hamacher-Brady A, Gottlieb RA. Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta 2006; 1757:667-678. doi: 10. 1016/j. bbabio. 2006. 04. 011 PMID: 16730326
30. Spiegel R, Saada A, Flannery PJ, Burte F, Soiferman D, KhayatM et al. Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation. J Med Genet 2016; 53:127-131. doi: 10. 1136/jmedgenet-2015-103361 PMID: 26561570
31. Fauconnier J, Roberge S, Saint N, Lacampagne A. Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion. Pharmacol Ther 2013; 138:323-332. doi: 10. 1016/j. pharmthera. 2013. 01. 015 PMID: 23384595
32. 2+ ATPase pump overexpression in a porcine model of ischemia reperfusion. Circulation 2008; 118:614-624. doi: 10. 1161/CIRCULATIONAHA. 108. 770883 PMID: 18645052
33. 2+ Exchanger in a Murine Model. Circ Arrhythm Electrophysiol 2015; 8:1210-1218. doi: 10. 1161/CIRCEP. 115. 002927 PMID: 26338832
34. 2+]i transients in murine ventricular myocytes. Circ Res 1998; 82:657-665. doi: 10. 1161/01. RES. 82. 6. 657 PMID: 9546374
35. 2+ exchanger in the pathophysiology of cardiac arrhythmia, ischemia and heart failure. Curr Drug Targets 2011; 12:737-747. doi: 10. 2174/138945011795378559 PMID: 21291388
36. Qu Z, Xie LH, Olcese R, Karagueuzian HS, Chen PS, Garfinkel A et al. Early afterdepolarizations in cardiac myocytes: beyond reduced repolarization reserve. Cardiovasc Res 2013; 99:6-15. doi: 10. 1093/cvr/cvt104 PMID: 23619423
37. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 2000; 87:275-281. doi: 10. 1161/01. RES. 87. 4. 275 PMID: 10948060
38. Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M et al. The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab 2015; 21:834-844. doi: 10. 1016/j. cmet. 2015. 05. 007 PMID: 26039448
39. Ikeda Y, Shirakabe A, Maejima Y, Zhai P, Sciarretta S, Toli J et al. Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ Res 2015; 116:264-278. doi: 10. 1161/CIRCRESAHA. 116. 303356 PMID: 25332205